Antimicrobial peptides, Vitamin D 3 and more;Antimikrobielle Peptide, Vitamin D 3 und mehr

Hautarzt

Volumn 62, Issue 11, 2011, Pages 815-819

  Schauber, J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cathelicidin; Pathogenesis; Proteases; Rosacea; Vitamin D 3

Indexed keywords

AZELAIC ACID; CATHELICIDIN; COLECALCIFEROL; DOXYCYCLINE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; RETINOID; TOLL LIKE RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; PATHOGENESIS; PROTEIN EXPRESSION; ROSACEA; ULTRAVIOLET IRRADIATION; VITAMIN METABOLISM;

ANTIMICROBIAL CATIONIC PEPTIDES; CHOLECALCIFEROL; CYTOKINES; HUMANS; MODELS, BIOLOGICAL; PEPTIDE HYDROLASES; ROSACEA; SKIN;

EID: 82955203389     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-011-2142-9     Document Type: Article

References (28)

1. Bonnar E, Eustace P, Powell FC (1993) The Demodex mite population in rosacea. J Am Acad Dermatol 28:443-448 (Pubitemid 23075260)
2. Da Silva CA, Hartl D, Liu W, et al. (2008) TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation. J Immunol 181:4279-4286
3. Del Rosso JQ, Webster GF, Jackson M, et al. (2007) Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol 56:791-802 (Pubitemid 46561002)
4. Gollnick H, Blume-Peytavi U, Szabo EL, et al. (2010) Systemic isotretinoin in the treatment of rosacea-doxycycline-and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 8:505-515
5. Gudmundsson GH, Agerberth B, Odeberg J, et al. (1996) The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 238:325-332 (Pubitemid 26188246)
6. Hata TR, Kotol P, Jackson M, et al. (2008) Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 122:829-831
7. Koczulla R, Von Degenfeld G, Kupatt C, et al. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111:1665-1672 (Pubitemid 38057748)
8. Lande R, Gregorio J, Facchinetti V, et al. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564-569 (Pubitemid 47525141)
9. Liu PT, Krutzik SR, Kim J, et al. (2005) Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol 174:2467-2470 (Pubitemid 40279655)
10. Morizane S, Yamasaki K, Kabigting FD, et al. (2010) Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. J Invest Dermatol 130:1297-1306
11. Murakami M, Lopez-Garcia B, Braff M, et al. (2004) Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol 172:3070-3077 (Pubitemid 38263696)
12. Peric M, Koglin S, Dombrowski Y, et al. (2009) Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis. PLoS One 4:e6340
13. Peric M, Koglin S, Kim SM, et al. (2008) IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol 181:8504-8512
14. Peric M, Lehmann B, Vashina G, et al. (2010) UV-B-triggered induction of vitamin D3 metabolism differentially affects antimicrobial peptide expression in keratinocytes. J Allergy Clin Immunol 125:746-749
15. Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258-265 (Pubitemid 43144395)
16. Schauber J, Dorschner RA, Coda AB, et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117:803-811 (Pubitemid 46348539)
17. Schauber J, Dorschner RA, Yamasaki K, et al. (2006) Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 118:509-519 (Pubitemid 44079569)
18. Schauber J, Gallo RL (2009) Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 124:R13-R18
19. Schauber J, Gallo RL (2007) Expanding the roles of antimicrobial peptides in skin: alarming and arming keratinocytes. J Invest Dermatol 127:510-512
20. Tenaud I, Khammari A, Dreno B (2007) In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol 16:500-506 (Pubitemid 46845393)
21. Thiboutot DM, Fleischer AB, Del Rosso JQ, et al. (2009) A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. J Drugs Dermatol 8:639-648
22. Vahavihu K, Ala-Houhala M, Peric M, et al. (2010) Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol 163:321-328
23. Wang TT, Nestel F, Bourdeau V, et al. (2004) Cutting edge: 1,25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909-2912 (Pubitemid 39141992)
24. Yamasaki K, Di Nardo A, Bardan A, et al. (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13:975-980 (Pubitemid 47222043)
25. Yamasaki K, Gallo RL (2010) Azelaic acid gel 15% alters kallikrein 5 and cathelicidin expression in epidermal keratinocytes, critical elements in the pathogenesis of rosacea. J Am Acad Dermatol 60:AB1
26. Yamasaki K, Gallo RL (2009) The molecular pathology of rosacea. J Dermatol Sci 55:77-81
27. Yamasaki K, Kanada K, Macleod DT, et al. (2011) TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol 131:688-697
28. Yamasaki K, Schauber J, Coda A, et al. (2006) Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 20:2068-2080 (Pubitemid 44953906)